Orthofix Medical (OFIX) SEC Filings: History & Chart

Orthofix Medical Inc.(OFIX)

Medical - Devices · Lewisville, TX

$9.41-0.09 (-0.95%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Orthofix Medical Inc.

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.

Lewisville, TX

1,605 employees

www.orthofix.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Massimo Calafiore

View full financials

Form	Filing Date	Accepted	Document
4	Oct 5, 2026	Oct 5, 2026	View filing
4/A	Sep 23, 2026	Sep 23, 2026	View filing
4	Sep 22, 2026	Sep 22, 2026	View filing
4	Sep 3, 2026	Sep 3, 2026	View filing
4	Aug 20, 2026	Aug 20, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
S-8	Aug 5, 2026	Aug 5, 2026	View filing
10-Q	Aug 5, 2026	Aug 5, 2026	View filing
8-K	Aug 5, 2026	Aug 5, 2026	View filing
8-K	Jul 2, 2026	Jul 2, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
4	Jun 12, 2026	Jun 12, 2026	View filing
8-K	Jun 11, 2026	Jun 11, 2026	View filing
4	May 29, 2026	May 29, 2026	View filing
3	May 29, 2026	May 29, 2026	View filing
SD	May 29, 2026	May 29, 2026	View filing
SC 13D/A	May 27, 2026	May 27, 2026	View filing
8-K	May 21, 2026	May 21, 2026	View filing
SC 13G/A	May 15, 2026	May 15, 2026	View filing
4	May 8, 2026	May 8, 2026	View filing
4	May 7, 2026	May 7, 2026	View filing

SEC Filings

Recent Filings